Dirk Lindenblatt

5PUBLICATIONS
24CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsBiologically active moleculesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 11, 2026
Discovery and characterization of a novel class of cyclic peptidic compounds inhibiting the subunit interaction of the protein kinase CK2α2β2 holoenzyme.

|Mar 21, 2025
Exploring the biological potential of the brominated indenoindole MC11 and its interaction with protein kinase CK2.

Christelle Marminon, Christian Werner, Alexander Gast

|Jul 29, 2021
Molecular Plasticity of Crystalline CK2α' Leads to KN2, a Bivalent Inhibitor of Protein Kinase CK2 with Extraordinary Selectivity.

Dirk Lindenblatt, Violetta Applegate, Anna Nickelsen

|Jun 27, 2020
Structural and Mechanistic Basis of the Inhibitory Potency of Selected 2-Aminothiazole Compounds on Protein Kinase CK2.

Dirk Lindenblatt, Anna Nickelsen, Violetta M Applegate

|Feb 21, 2019
Design of CK2β-Mimicking Peptides as Tools To Study the CK2α/CK2β Interaction in Cancer Cells.

Dirk Lindenblatt, Mareike Horn, Claudia Götz

Pageof 1

Frequent Collaborators

5 joint publications

Karsten Niefind

3 joint publications

Joachim Jose

2 joint publications

Ines Neundorf

2 joint publications

Markus Pietsch